For the Inventor, By the Inventor

Enter assignee name

Boulder, CO, United States of America

University Research Corporation

Calculating rank

USPTO Granted Patents = 20

Forward Citations = 2,102

Loading Chart...

Loading Chart...

28 inventors (with patents filed for the assignee):

David M Walba (8 out of 31 patents)

Larry M Gold (6 out of 191 patents)

Thomas R Cech (3 out of 42 patents)

4. Michael D Wand (3 out of 34 patents)

5. Rohini T Vohra (3 out of 14 patents)

6. James A Rego (3 out of 3 patents)

7. Maria B Ros (3 out of 3 patents)

8. Teresa Sierra (3 out of 3 patents)

9. Bruce A Sullenger (3 out of 3 patents)

10. Craig Tuerk (2 out of 18 patents)

11. Daniel J Schneider (1 out of 33 patents)

12. John C Price (1 out of 10 patents)

13. Frank S Barnes (1 out of 16 patents)

14. Sharon L Potter (1 out of 11 patents)

15. Claude P Selitrennikoff (1 out of 10 patents)

20 patents: Sort by Forward Citations

1. 5981844 - Synergistic antifungal protein and compositions containing same (1999-11-09),

2. 5869254 - Alteration of sequence of a target molecule by ribozyme catalyzed (1999-02-09),

3. 5854038 - Localization of a therapeutic agent in a cell in vitro (1998-12-29),

4. 5721194 - Tuneable microwave devices including fringe effect capacitor (1998-02-24),

5. 5667969 - Alteration of sequence of a deleterious target molecule by ribozyme (1997-09-16),

6. 5658493 - Ferroelectric liquid crystals for nonlinear optics applications (1997-08-19),

7. 5648214 - High-affinity oligonucleotide ligands to the tachykinin substance P (1997-07-15),

8. 5637256 - Ferroelectric liquid crystals for nonlinear optics applications (1997-06-10),

9. 5596434 - Self-assembled monolayers for liquid crystal alignment (1997-01-21),

10. 5587468 - High affinity nucleic acid ligands to HIV integrase (1996-12-24),

11. 5567588 - Systematic evolution of ligands by exponential enrichment: Solution SELEX (1996-10-22),

12. 5543078 - Ferroelectric liquid crystals for nonlinear optics applications (1996-08-06),

13. 5503978 - Method for identification of high affinity DNA ligands of HIV-1 reverse (1996-04-02),

14. 5475096 - Nucleic acid ligands (1995-12-12),

15. 5270163 - Methods for identifying nucleic acid ligands (1993-12-14),

Company Overview

University Research Corporation (URC) is a prominent organization based in Boulder, Colorado, specializing in health and social services research. URC focuses on developing innovative solutions to improve healthcare delivery and outcomes, particularly in underserved populations. The organization engages in various research domains, including public health, program evaluation, and health systems strengthening, contributing to evidence-based practices and policies that enhance community well-being and health equity.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

20 Patents

#64 in Boulder, CO

#331 in Colorado

#16,416 in US

#31,315 in the World

Boulder, CO, United States of America

University Research Corporation

Forward Citations = 2,102

28 inventors:

David M Walba (8 out of 31 patents)

Larry M Gold (6 out of 191 patents)

Thomas R Cech (3 out of 42 patents)

4. Michael D Wand (3 out of 34 patents)

5. Rohini T Vohra (3 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: University Research Corporation. Retrieved from https://idiyas.com/company/university-research

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…